Novo Nordisk Pharmatech

Name

Novo Nordisk Pharmatech

Legal name

Novo Nordisk Pharmatech A/S

Website

https://novonordiskpharmatech.com

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical raw materials manufacturing

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose) (CRADAOAF)

Keywords

• Pharmaceutical raw materials
• Recombinant insulin manufacturing
• Biopharmaceutical cell culture supplements
• Pharmaceutical grade benzalkonium chloride
• CGMP contract manufacturing

Headquarters

HQ city

Køge

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Recombinant Insulin (Insulin Human AF): Sale of high-purity, animal-free recombinant insulin for use in cell culture media, supporting biomanufacturing of monoclonal antibodies, virus vaccines, gene therapy products, and pluripotent stem cells. Insulin is approved by FDA and EMA and is a vital ingredient in over 100 therapeutic drugs. Sold in quantities from 1g to 1kg.
2. TrypsiNNex® (Recombinant Trypsin): Sale of animal-free recombinant trypsin for cell dissociation, virus propagation, protein processing, and modification of viral and protein-based products. Available in multiple sizes (0.5 MU, 5 MU, 50 MU). GMP manufactured.
3. Benzalkonium Chloride (BKC): Sale of pharmaceutical-grade Benzalkonium Chloride for use as APIs and excipients in pharmaceutical formulations. Multi-compendial product compliant with major pharmacopoeias.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels5 records

Core offering

Novo Nordisk Pharmatech manufactures and supplies three pharmaceutical-grade raw material lines for biopharmaceutical and pharmaceutical manufacturers: Recombinant Insulin (Insulin Human AF) used as a cell culture media supplement for biologics, vaccine, and gene therapy production; TrypsiNNex®, an animal-free recombinant porcine trypsin used for cell dissociation and virus/protein processing; and Benzalkonium Chloride (BKC), a multi-compendial API and excipient for topical, ophthalmic, and nasal formulations. All products are produced under cGMP at the company's Køge, Denmark facility and sold directly to enterprise customers via quotation.

Product overview

Novo Nordisk Pharmatech is a specialist manufacturer and supplier of pharmaceutical-grade raw materials for biopharmaceutical and pharmaceutical manufacturing. The company operates three core product lines: TrypsiNNex® (animal-free recombinant trypsin enzyme), Recombinant Insulin (Insulin Human AF), and Benzalkonium Chloride (BKC). These products serve as critical ingredients and process aids in the manufacture of biologics, vaccines, cell and gene therapies, and pharmaceutical formulations. The company is a subsidiary of Novo Nordisk, leveraging over 100 years of insulin expertise.

Differentiator

Problem solved

Functional benefit

Brands

• TrypsiNNex: Animal-free recombinant porcine trypsin for biopharmaceutical manufacturing processes, including cell dissociation, virus production, and protein processing.

Products and services

• Recombinant Insulin (Insulin Human AF) High-purity, animal-free recombinant human insulin used as a cell culture media supplement for biomanufacturing of monoclonal antibodies, virus vaccines, gene therapy products, and pluripotent stem cells. Available in pack sizes from 1g to 1kg. Approved by FDA and EMA and used as an ingredient in over 100 therapeutic drugs.
• TrypsiNNex® (Recombinant Porcine Trypsin) Animal-free recombinant porcine trypsin expressed in E. coli in inactive form to prevent auto-degradation, with ≥90% product purity and ≥70% β-trypsin content. GMP manufactured per IPEC guidelines; sequence identical to native porcine trypsin for direct drop-in replacement. Used for cell dissociation, virus propagation, and protein processing. Available in 0.5 MU, 5 MU, and 50 MU pack sizes.
• Benzalkonium Chloride (BKC) Pharmaceutical-grade Benzalkonium Chloride (BKC) supplied as both API and excipient for topical, ophthalmic, nasal, and multi-dose pharmaceutical formulations. Multi-compendial range complying with ICH Q7, European Pharmacopoeia, US Pharmacopoeia, Japanese Pharmacopoeia, and British Pharmacopoeia; cGMP manufactured with 70+ years of manufacturing experience.

Quantifiable outcome

• Up to 1.7-fold increase in influenza virus production in HEK293 cells
• +7 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• ActyliscoreChannel Partner/ Reseller/ Distributor · 1 January 2024Actylis is an authorized distributor of Novo Nordisk Pharmatech, covering Canada, Benelux, Scandinavia, Germany, France, UK, Ireland, Spain, and Portugal for Benzalkonium Chloride distribution in the USA. The partnership was expanded in 2024 to include distribution of Benzalkonium Chloride in the United States.
• BrenntagcoreChannel Partner/ Reseller/ DistributorBrenntag is an authorized distributor of Novo Nordisk Pharmatech covering the USA market.
• DKSHcoreChannel Partner/ Reseller/ DistributorDKSH is an authorized distributor of Novo Nordisk Pharmatech covering the Asia Pacific region including Australia, China, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Taiwan, and Vietnam.
• IMCDcoreChannel Partner/ Reseller/ DistributorIMCD is an authorized distributor of Novo Nordisk Pharmatech covering Italy.
• SelectchemiecoreChannel Partner/ Reseller/ DistributorSelectchemie is an authorized distributor of Novo Nordisk Pharmatech covering Switzerland, Austria, Greece, Slovenia, Croatia, Bosnia Herzegovina, Bulgaria, Romania, Moldova, Ukraine, Hungary, Slovakia, Czech Republic, Poland, Lithuania, Latvia, Estonia, Turkey, North Africa (Egypt), and South America (Peru, Argentina).
• Universitat Autònoma de BarcelonaminorStrategic or Co-development PartnerCollaborative study on boosting protein productivity in CHO-S cells through cell culture media optimization using Recombinant Insulin. Study conducted in collaboration with Universitat Autònoma de Barcelona.
• National Research Council CanadaminorStrategic or Co-development PartnerCollaborative study on boosting influenza virus production in HEK293 cells with Recombinant Insulin. Study performed in collaboration with the National Research Council Canada.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• BASF: Global chemical company producing a wide range of pharmaceutical excipients and APIs. Overlaps with NNP's BKC and pharmaceutical ingredient offerings within a much broader chemicals portfolio.
• Lonza Group: Global CDMO and bioprocessing services provider with cell culture media and process development offerings. Overlaps with NNP's bioprocessing customer base though its primary business is contract manufacturing.
• Thermo Fisher Scientific: Large life sciences incumbent with the Gibco cell culture media brand serving biopharmaceutical manufacturers globally. Overlaps with NNP's insulin and trypsin offerings as part of a much broader portfolio.
• Merck KGaA (MilliporeSigma): Life science tools and bioprocessing raw materials provider through its MilliporeSigma division. Competes with NNP in cell culture supplements and pharmaceutical excipients as part of a much broader portfolio.

Direct peers

• Kerry Group: Taste and nutrition company with a pharmaceuticals and bioprocessing ingredients division. Comparable to NNP's role as a specialty ingredients supplier to life sciences customers, though more diversified.
• Cytiva: Bioprocessing solutions provider (part of Danaher) offering cell culture media, single-use technologies, and process services. Directly competes with NNP in cell culture supplements for biomanufacturing.
• FUJIFILM Irvine Scientific: Specialist manufacturer of cell culture media and supplements for biopharmaceutical, cell therapy, and regenerative medicine applications. Direct competitor in cell culture supplements to biomanufacturers.
• Avantor: Distributor and manufacturer of bioprocessing raw materials and laboratory products. Comparable to NNP's role as a specialty supplier to biopharmaceutical manufacturers, with overlap on distribution channels.
• Sartorius AG: Global bioprocessing solutions provider offering cell culture media, bioreactors, and filtration products. Directly comparable to NNP's bioprocessing raw materials focus, though broader in product scope.
• Croda International: Specialty chemicals company producing pharmaceutical excipients and active ingredients for life sciences applications. Comparable to NNP's BKC product line and broader pharmaceutical ingredients portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novo Nordisk Pharmatech